SCHEMBL4768161

SCHEMBL4768161

Cc1nn(-c2ccccc2)nc1C(=O)Nc1ccc2c(c1)CCN(C1CCC1)CC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 1/20 0.52
HRH3 Q9Y5N1 7/20 0.44
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
NFKB1 P19838 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ITGB1 P05556 1/20 0.42
ITGA4 P13612 1/20 0.42
LMNA P02545 1/20 0.41
ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4770820 0.98 POLB (0.56) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL4768152 0.97 POLB (0.55) POLBKDM4EMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4768205 0.96 POLB (0.54) POLBKDM4EMEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL4765180 0.94 POLB (0.52) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL4772525 0.93 POLB (0.46) POLBKDM4EMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4774047 0.92 POLB (0.46) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL4770197 0.90 POLB (0.53) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL4770727 0.90 POLB (0.53) POLBKDM4EMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4770711 0.89 POLB (0.52) POLBKDM4EMEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL4772752 0.86 POLB (0.49) POLBKDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 POLB 4330/4885KDM4E 488/4885MEN1 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.